SHP Wealth Management’s Bio-Techne TECH Stock Holding History

SHP Wealth Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.91K	Buy	27 +18	+200%	+$972	﹤0.01%	1416
2026 Q1	$470	Buy	+9	New	+$540	﹤0.01%	1629

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

SHP Wealth Management's TECH Position: Q2 2026 in Review

SHP Wealth Management increased its Bio-Techne (TECH) stake by 200% in Q2 2026, buying an estimated $972 and bringing the position to 27 shares worth $1.91K. The position accounts for ﹤0.01% of the portfolio, ranked #1416.

SHP Wealth Management first reported a position in TECH in Q1 2026 and has held it in 2 quarters since. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

SHP Wealth Management held 27 shares of Bio-Techne worth $1.91K as of Q2 2026.
SHP Wealth Management bought 18 Bio-Techne shares in Q2 2026, an estimated $972.
Bio-Techne made up ﹤0.01% of SHP Wealth Management's portfolio in Q2 2026, its #1416 holding.
SHP Wealth Management first reported a position in Bio-Techne in Q1 2026 and has held it in 2 quarters since.
596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on SHP Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.